Molecular jackhammers’ ‘good vibrations’ eradicate cancer cells
On Dec. 19, 2023, a research team led by Rice University reported they found that the atoms of…
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Genomics | Nanotechnology | Neurology | Non-Profit Research | Pharmaceutical | Therapeutics
PNNL created Center for Artificial Intelligence
On Dec. 14, 2023, the Department of Energy’s (DOE) Pacific Northwest National Laboratory (PNNL) announced that it had…
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Therapeutics
Alberta researchers revealed full structure of ‘ancient genetic parasite’ implicated in human diseases
On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…
ZURZUVAE (zuranolone) CIV, a landmark treatment for women with postpartum Depression, available in the U.S.
On Dec. 14, 2023, Biogen and Sage Therapeutics announced ZURZUVAE (zuranolone) 50 mg (two 25 mg capsules per…
Biotechnology | Diagnostics | Disease | NIH | Therapeutics
Scientists unveiled complete cell map of a whole mammalian brain
On Dec. 13, 2023, for the first time ever, an international team of researchers announced they had created…
CRISPR | Genomics | Stem Cell | Therapeutics
FDA approved first gene therapies to treat patients with sickle cell disease
On Dec. 8, 2023, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing…
Biotechnology | CRISPR | FDA | Genomics | Therapeutics
Vertex and CRISPR Therapeutics announced U.S. FDA approval of CASGEVY for treatment of sickle Cell disease
On Dec. 8, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
bluebird bio announced commercial launch of LYFGENIA’ gene therapy for patients ages 12 and older with sickle cell disease
On Dec. 8, 2023, bluebird bio announced the U.S. commercial launch of its LYFGENIA’ (lovotibeglogene autotemcel, also known…
University of Wisconsin-Madison sewer sleuthing, air vacuuming scientists keep tabs on COVID-19
On Dec. 4 2023, the University of Wisconsin-Madison researchers announced that while analyzing data from wastewater samples collected…
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Oncology | Therapeutics
World’s largest genetic project unveiled incredible new data
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
Biotechnology | Clinical Research | COVID-19 | FDA | Infectious Disease | Medicine | NIH | Therapeutics | Vaccine
FDA issued final guidance on developing drugs for COVID-19 treatment and preventionﾠ
On Nov. 22, 2023, the U.S. Food and Drug Administration (FDA) issued the final guidance COVID-19: Developing Drugs…
Vertex and CRISPR Therapeutics announced authorization of first CRISPR/Cas9 gene-edited therapy by UK MHRA for treatment of Sickle Cell Disease
On Nov. 16, 2023, Vertex and CRISPR Therapeutics announced that the United Kingdom (U.K.) Medicines and Healthcare products…
CPRIT invested $63 million to bring innovative researchers and companies to Texas
On Nov. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
WHO reported Marburg virus disease outbreak in Equatorial Guinea
On Nov. 13, 2023, the World Health Organization (WHO announced that the Ministry of Health and Social Welfare…
The White House lanuched Initiative on Women’s Health Research
On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenﾒs Health Research, an effort led…
Surgeons in New York announced world’s first eye transplant
On Nov. 10, 2023, surgeons in New York announced they had performed the first-ever whole-eye transplant in a…
FDA approved new medication for chronic weight management
On Nov. 8, 2023, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound (tirzepatide) injection for chronic…
Biotechnology | Disease | FDA | Therapeutics
FDA approved interchangeable biosimilar for multiple inflammatory diseases
On Oct. 31, 2023, the U.S. Food and Drug Administration (FDA) announced it had approved Amgen’s Wezlana (ustekinumab-auub)…
First locally acquired case of dengue in California detected in a Pasadena resident
On Oct. 30, 2023, the California Department of Public Health (CDPH) reported the first locally acquired case of…
Biotechnology | Diagnostics | Medical Device | Neurology | Non-Profit Research | Stem Cell | Therapeutics
California’s Stem Cell Agency invested more than $42.1 million in translational-stage research
On Oct. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $42.1 million to fund various translational…
U.S. CDC reported high rates of child flu hospitalizations recorded in 2022-2023 season
On Oct. 20, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that among children and…
Purdue named new pediatric cancer research center for the late Tyler Trent
On Oct. 14, 2023, Purdue University ensured that the memory of the former graduate and devoted Boilermaker football…
California’s Stem Cell Agency approved $110 million investment into basic research in neuropsychiatric diseases
On Oct. 2, 2023, the California Institute for Regenerative Medicine (CIRM) announced its approval of a new program…
COVID-19 | CRISPR | Therapeutics | Vaccine
Nobel Prize in medicine was jointly awarded to Katalin Kariko and Drew Weissman “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”
On Oct. 2, 2023, the Nobel Prize in Physiology or medicine was awarded jointly to Katalin Kariko and…
California’s Stem Cell Agency invested $44 million to advance regenerative medicine research and manufacturing in California
On Sept. 29, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $43.8 million to fund projects aimed…
U.S. National Science Foundation invested $35 million in future manufacturing
On Sept. 29, 2023, through the Future Manufacturing program, the U.S. National Science Foundation (NSF) announced targeted investments…
Ligand Acquires Assets of Novan for $12.2 Million
On Sep. 27, 2023, Ligand Pharmaceuticals announced that it has closed the transaction to acquire assets of Novan following…
Diagnostics | Disease | Medical Device | NIH | Oncology | Therapeutics | U.S. Congress
ARPA-H launched program for real-time drug delivery and disease tracking to improve patient self-care
On Sept. 26, 2023, the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department…
West Nile virus reported in humans and horses from four counties in Washington state
On Sept. 25, 2023, the Washington State Department of Health confirmed the presence of West Nile virus in…
Biotechnology | HIV | NIH | Non-Profit Research | Therapeutics | Vaccine
Clinical trial of HIV vaccine began in United States and South Africa
On Sept. 20, 2023, the National Institutes of Health announced that a trial of a preventive HIV vaccine…